Evidence map›Paper›PMID 41497599›Full record

ArticlebioRxiv : the preprint server for biology2025

Genetic and environmental imprints on T cell receptor repertoires as predictors of graft-versus-host disease.

Assya Trofimov, Zachary Montague, Magdalena L Russell, Rachel Bender Ignacio, Terry Stevens-Ayers, Danniel Zamora, Marco Mielcarek, Michael J Boeckh, Frederick Matsen, Armita Nourmohammad

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Assya TrofimovDepartment of Physics, University of Washington, 3910 15th Avenue Northeast, Seattle, WA 98195, USA.ORCID 0000-0001-8748-3735
Zachary MontagueDepartment of Physics, University of Washington, 3910 15th Avenue Northeast, Seattle, WA 98195, USA.ORCID 0000-0003-0976-0447
Magdalena L RussellFred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA 98102, USA.ORCID 0000-0002-1068-1968
Rachel Bender IgnacioFred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA 98102, USA.ORCID 0000-0001-6167-1447
Terry Stevens-AyersFred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA 98102, USA.ORCID 0000-0002-7546-8439
Danniel ZamoraFred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA 98102, USA.ORCID 0000-0002-1318-2902
Marco MielcarekFred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA 98102, USA.ORCID 0000-0002-5680-8688
Michael J BoeckhFred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA 98102, USA.ORCID 0000-0003-1538-7984
Frederick MatsenFred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA 98102, USA.ORCID 0000-0003-0607-6025
Armita NourmohammadDepartment of Physics, University of Washington, 3910 15th Avenue Northeast, Seattle, WA 98195, USA.ORCID 0000-0002-6245-3553

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptorsR01AI146028 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2019 to 2024
$3.4M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
Learning a molecular shape space for the adaptive immune systemR35GM142795 · NIGMS · UNIVERSITY OF WASHINGTON · PI NOURMOHAMMAD, ARMITA · 2021 to 2025
$1.8M
NCI NIH HHS P30 CA015704NIAID NIH HHS R01 AI146028NIGMS NIH HHS R35 GM142795NIH HHS S10 OD028685
6 · The paper itself

Abstract

Hematopoietic cell transplantation (HCT) as potentially curative treatment for patients with hematologic malignancies relies on T cells to mediate the potentially curative graft-versus-tumor (GVT) effect, which may be associated with graft-versus-host disease (GVHD), a potentially life-threatening complication. T cells recognize peptides presented by Human Leukocyte Antigen (HLA) molecules. It is commonly believed that matching HLA alleles between donors and recipients ensures similarity in their T cell receptor (TCR) repertoires, thereby reducing the risk of GVHD and graft rejection. However, TCR repertoires are shaped by multiple factors beyond HLA genetics, including sex, age, and immune history. The extent to which genetic variation and past infections influence TCR repertoire composition and GVHD risk remains unclear. Here, we show that while HLA haplotypes contribute to broad TCR repertoire differences, recent viral infections significantly impact TCR composition and influence GVHD risk. Analyzing 401 patients who were uniformly transplanted from healthy HLA-identical sibling HCT donors, we introduced

Identifiers

PMID41497599
PMCPMC12767534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.